School of Medicine

The Latest

Q&A: Strengthening Antibody Armor for Tripledemic Times

This season there are three prevalent respiratory viruses to be aware of—influenza, SARS-CoV-2 and respiratory syncytial virus (RSV), all of which are transmitted via aerosols.

Study: First-Degree Relatives of Patients with NAFLD at Risk of Liver Disease

New study identifies that first-degree relatives of patients with nonalcoholic fatty liver disease with advanced fibrosis (scarring of the liver) are at a 15% risk of developing the condition.

Appendiceal Cancer Gets Its Own Preclinical Model

Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe the first preclinical model of appendiceal cancer that contains all elements of the tumor, allowing previously stymied investigations to proceed.

Collaborations by UC San Diego Researchers Win Cluster of National Awards

The U.S. National Science Foundation announced $30 million in research awards to support new interdisciplinary, fundamental research projects for the Emerging Frontiers in Research and Innovation (EFRI) program — 20 percent of the funding was awarded to UC San Diego researchers.

Student scientist in lab coat hold green vial with protective gloves.

Genetic Score Predicts Risk of Lethal Prostate Cancer

Researchers at UC San Diego report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer, which kills more than 34,000 men in the U.S. annually.

Treated or Not, COVID-19 Recurrence Seems Symptomatic for Some

UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.